Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1993 Nov;70(5):409–414. doi: 10.1136/hrt.70.5.409

Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.

T Omland 1, V V Bonarjee 1, D W Nilsen 1, J A Sundsfjord 1, R T Lie 1, G Thibault 1, K Dickstein 1
PMCID: PMC1025351  PMID: 8260270

Abstract

OBJECTIVE--To evaluate the prognostic significance of plasma N-terminal pro-atrial natriuretic factor (1-98) concentrations measured in the subacute phase after acute myocardial infarction, and to compare the predictive value of measurement of N-terminal pro-atrial natriuretic factor (1-98) with the measurement of atrial natriuretic factor (99-126) and with clinical assessment of the degree of heart failure. DESIGN--Prospective observational. SETTING--Norwegian central hospital. PATIENTS--139 patients (mean (SD) age 66.9 (11.1) years, 71.2% males) with acute myocardial infarction. Patients in cardiogenic shock or with severe heart failure (New York Heart Association class IV) were excluded. MAIN OUTCOME MEASURE--Cardiovascular death within 12 months. RESULTS--During the follow up period 15 patients died. In a univariate Cox proportional hazards model N-terminal pro-atrial natriuretic factor (1-98) was significantly related to mortality (p = 0.0003). In a multivariate model the prognostic value of N-terminal pro-atrial natriuretic factor (1-98) was better than that of atrial natriuretic factor (99-126) and clinical assessment of heart failure (N-terminal pro-atrial natriuretic factor (1-98), p = 0.0003; atrial natriuretic factor (99-126), p = 0.4513; heart failure, p = 0.0719). The odds ratio estimate of patients in whom plasma concentrations of N-terminal pro-atrial natriuretic factor (1-98) were greater than 2000 pmol/l was 25 (95% confidence interval 2.8-225.0) compared with patients with plasma concentrations less than 1000 pmol/l. CONCLUSIONS--These results suggest that determination of plasma N-terminal pro-atrial natriuretic factor (1-98) in the subacute phase of myocardial infarction may provide clinically relevant prognostic information that is superior to that obtained from atrial natriuretic factor (99-126) measurements and clinical evaluation.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker B. J., Wu W. C., Winters C. J., Dinh H., Wyeth R., Sallman A. L., Vesely D. L. Exercise increases the circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in normal individuals. Am Heart J. 1991 Nov;122(5):1395–1402. doi: 10.1016/0002-8703(91)90583-4. [DOI] [PubMed] [Google Scholar]
  2. Bates E. R., Shenker Y., Grekin R. J. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation. 1986 Jun;73(6):1155–1161. doi: 10.1161/01.cir.73.6.1155. [DOI] [PubMed] [Google Scholar]
  3. Buckley M. G., Sagnella G. A., Markandu N. D., Singer D. R., MacGregor G. A. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure. Clin Sci (Lond) 1989 Nov;77(5):573–579. doi: 10.1042/cs0770573. [DOI] [PubMed] [Google Scholar]
  4. Crozier I. G., Nicholls M. G., Ikram H., Espiner E. A., Gomez H. J., Warner N. J. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986 Nov 29;2(8518):1242–1245. doi: 10.1016/s0140-6736(86)92675-9. [DOI] [PubMed] [Google Scholar]
  5. Edwards B. S., Zimmerman R. S., Schwab T. R., Heublein D. M., Burnett J. C., Jr Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res. 1988 Feb;62(2):191–195. doi: 10.1161/01.res.62.2.191. [DOI] [PubMed] [Google Scholar]
  6. Fontana F., Bernardi P., Spagnolo N., Capelli M. Plasma atrial natriuretic factor in low output heart failure syndromes. Klin Wochenschr. 1990 Mar 16;68(6):313–319. doi: 10.1007/BF01649022. [DOI] [PubMed] [Google Scholar]
  7. Fontana F., Bernardi P., Spagnolo N., Capelli M. Plasma atrial natriuretic factor in patients with acute myocardial infarction. Eur Heart J. 1990 Sep;11(9):779–787. doi: 10.1093/oxfordjournals.eurheartj.a059797. [DOI] [PubMed] [Google Scholar]
  8. Gottlieb S. S., Kukin M. L., Ahern D., Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. doi: 10.1016/0735-1097(89)90344-6. [DOI] [PubMed] [Google Scholar]
  9. Itoh H., Nakao K., Sugawara A., Saito Y., Mukoyama M., Morii N., Yamada T., Shiono S., Arai H., Hosoda K. Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP. J Clin Endocrinol Metab. 1988 Sep;67(3):429–437. doi: 10.1210/jcem-67-3-429. [DOI] [PubMed] [Google Scholar]
  10. Jougasaki M., Yasue H., Mukoyama M., Nakao K., Takahashi K. Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction. Am Heart J. 1990 Jan;119(1):92–96. doi: 10.1016/s0002-8703(05)80087-0. [DOI] [PubMed] [Google Scholar]
  11. Martin D. R., Pevahouse J. B., Trigg D. J., Vesely D. L., Buerkert J. E. Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and/or kaliuretic. Am J Physiol. 1990 May;258(5 Pt 2):F1401–F1408. doi: 10.1152/ajprenal.1990.258.5.F1401. [DOI] [PubMed] [Google Scholar]
  12. Matsubara H., Nishikawa M., Umeda Y., Taniguchi T., Iwasaka T., Kurimoto T., Yamane Y., Inada M. The role of atrial pressure in secreting atrial natriuretic polypeptides. Am Heart J. 1987 Jun;113(6):1457–1463. doi: 10.1016/0002-8703(87)90662-4. [DOI] [PubMed] [Google Scholar]
  13. Münzel T., Kurz S., Holtz J., Busse R., Steinhauer H., Just H., Drexler H. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 1992 Oct;86(4):1089–1098. doi: 10.1161/01.cir.86.4.1089. [DOI] [PubMed] [Google Scholar]
  14. Nakamura M., Arakawa N., Kato M. Renal, hormonal, and hemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction. Am Heart J. 1990 Nov;120(5):1078–1085. doi: 10.1016/0002-8703(90)90119-i. [DOI] [PubMed] [Google Scholar]
  15. Ngo L., Vesely D. L., Bissett J. K., Murphy M. L., Dinh H., Sallman A. L., Rico D. M., Winters C. J., Wyeth R. P. Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarction. Am J Med Sci. 1991 Mar;301(3):157–164. doi: 10.1097/00000441-199103000-00002. [DOI] [PubMed] [Google Scholar]
  16. Odemuyiwa O., Malik M., Farrell T., Bashir Y., Poloniecki J., Camm J. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol. 1991 Aug 15;68(5):434–439. doi: 10.1016/0002-9149(91)90774-f. [DOI] [PubMed] [Google Scholar]
  17. Omland T., Barvik S., Aakvaag A., Aarsland T., Dickstein K. Plasma atrial natriuretic factor concentration during maximal cardiopulmonary exercise in men with mild heart failure. Int J Cardiol. 1990 Nov;29(2):179–184. doi: 10.1016/0167-5273(90)90220-y. [DOI] [PubMed] [Google Scholar]
  18. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  19. Richards A. M., Cleland J. G., Tonolo G., McIntyre G. D., Leckie B. J., Dargie H. J., Ball S. G., Robertson J. I. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):409–412. doi: 10.1136/bmj.293.6544.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  21. Sundsfjord J. A., Thibault G., Larochelle P., Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab. 1988 Mar;66(3):605–610. doi: 10.1210/jcem-66-3-605. [DOI] [PubMed] [Google Scholar]
  22. Svanegaard J., Angelo-Nielsen K., Pindborg T. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J. 1992 Jul;68(1):38–42. doi: 10.1136/hrt.68.7.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  24. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  25. Takemura G., Fujiwara H., Mukoyama M., Saito Y., Nakao K., Kawamura A., Ishida M., Kida M., Uegaito T., Tanaka M. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation. 1991 Jan;83(1):181–190. doi: 10.1161/01.cir.83.1.181. [DOI] [PubMed] [Google Scholar]
  26. Tan A. C., Kloppenborg P. W., Benraad T. J. Storage and thawing influence plasma levels of immunoreactive atrial natriuretic peptide. Clin Chim Acta. 1990 Oct 31;191(1-2):111–113. doi: 10.1016/0009-8981(90)90067-3. [DOI] [PubMed] [Google Scholar]
  27. Tan A. C., van Loenhout T. T., Lamfers E. J., Hooghoudt T. E., Kloppenborg P. W., Benraad T. J. Atrial natriuretic peptide after myocardial infarction. Am Heart J. 1989 Sep;118(3):490–494. doi: 10.1016/0002-8703(89)90262-7. [DOI] [PubMed] [Google Scholar]
  28. Thibault G., Garcia R., Gutkowska J., Bilodeau J., Lazure C., Seidah N. G., Chrétien M., Genest J., Cantin M. The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor. Biochem J. 1987 Jan 1;241(1):265–272. doi: 10.1042/bj2410265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thibault G., Murthy K. K., Gutkowska J., Seidah N. G., Lazure C., Chrétien M., Cantin M. NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides. 1988 Jan-Feb;9(1):47–53. doi: 10.1016/0196-9781(88)90008-3. [DOI] [PubMed] [Google Scholar]
  30. Tomoda H. Atrial natriuretic peptide in acute myocardial infarction. Am J Cardiol. 1988 Nov 15;62(16):1122–1123. doi: 10.1016/0002-9149(88)90561-9. [DOI] [PubMed] [Google Scholar]
  31. Tsutamoto T., Bito K., Kinoshita M. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. Am Heart J. 1989 Mar;117(3):599–606. doi: 10.1016/0002-8703(89)90734-5. [DOI] [PubMed] [Google Scholar]
  32. Vesely D. L., Norris J. S., Walters J. M., Jespersen R. R., Baeyens D. A. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1540–1548. doi: 10.1016/s0006-291x(87)80307-8. [DOI] [PubMed] [Google Scholar]
  33. White H. D., Norris R. M., Brown M. A., Brandt P. W., Whitlock R. M., Wild C. J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76(1):44–51. doi: 10.1161/01.cir.76.1.44. [DOI] [PubMed] [Google Scholar]
  34. Winters C. J., Baker B. J., Dinh H., Sallman A. L., Rico D. M., Vesely D. L. Prohormone atrial natriuretic peptides 1-98 and 31-67 increase with exercise in congestive heart failure patients. Am J Med Sci. 1989 Dec;298(6):377–382. doi: 10.1097/00000441-198912000-00004. [DOI] [PubMed] [Google Scholar]
  35. Winters C. J., Sallman A. L., Baker B. J., Meadows J., Rico D. M., Vesely D. L. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation. 1989 Sep;80(3):438–449. doi: 10.1161/01.cir.80.3.438. [DOI] [PubMed] [Google Scholar]
  36. Yandle T. G., Richards A. M., Nicholls M. G., Cuneo R., Espiner E. A., Livesey J. H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 1986 May 19;38(20):1827–1833. doi: 10.1016/0024-3205(86)90137-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES